Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed3

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Research Network

Collaboration Network

6 collaborators·15 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Daniel Furst, MD

UCLA Medical School

Related
1 trials

Shared therapeutic areas:

Scleroderma, SystemicSclerosis

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score24%

Maureen Mayes, MD, MPH

The University of Texas Health Science Center, Houston

Related
1 trials

Shared therapeutic areas:

Scleroderma, SystemicSclerosis

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score24%

Keith Sullivan, MD

Division of Cellular Therapy, Duke University

Related
1 trials

Shared therapeutic areas:

Scleroderma, SystemicSclerosis

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score24%

Leslie J. Crofford, MD

University of Michigan

Related
1 trials

Shared therapeutic areas:

Scleroderma, SystemicSclerosis

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score24%

Peter McSweeney, MD

Blood and Marrow Transplant Program, Presbyterian/St. Luke's Medical Center, Rocky Mountain Cancer Center

Related
1 trials

Shared therapeutic areas:

Scleroderma, SystemicSclerosis

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score24%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesChronic Myeloproliferative Disorders+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score14%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphomaGraft vs Host Disease+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score14%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Graft vs Host DiseaseLymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Graft vs Host DiseaseLeukemiaLymphoma
Similarity Score8%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00005941Phase 2StudyChair

Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer

Cervical CancerVaginal Cancer
Completed
NCT00096096Phase 2PrincipalInvestigator

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Completed
NCT00860548StudyChair

SCOT Scleroderma Treatment Alternative Registry (STAR Registry)

Scleroderma, SystemicSclerosis
Completed

All 3 trials loaded